Stock data
Assembly Biosciences, Inc. (ASMB)
Assembly Biosciences, Inc. (ASMB) reported revenue of US$72.30M and net income of -US$6.12M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$72.30M | — | -US$12.12M | -US$6.12M | — |
| 2024 | US$28.52M | — | -US$45.42M | -US$40.18M | — |
| 2023 | — | — | -US$64.65M | -US$61.23M | — |
| 2022 | — | — | -US$94.11M | -US$93.09M | — |
| 2021 | — | — | -US$132.69M | -US$129.85M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$3.86M | — |
| 2026-03-31 | — | -US$9.08M | — |
| 2025-12-31 | — | US$22.09M | — |
| 2025-09-30 | — | -US$9.20M | — |
| 2025-06-30 | — | -US$10.20M | — |
| 2025-03-31 | — | -US$8.82M | — |
| 2024-12-31 | — | -US$10.34M | — |
| 2024-09-30 | — | -US$9.61M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.